ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,245
0,58%
Bitcoin
63 863,86
-0,04%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Codexis Inc (CDXS)

  7. Codexis Inc (CDXS) Actualités

CDXS Codexis Inc

3,95
0,61 (18,26%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Codexis Inc CDXS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,61 18,26% 3,95 06:00:14
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,62 3,53 4,01 3,92 3,34
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202422:05GLOBECodexis Reports First Quarter 2024 Financial Results
18/4/202422:05GLOBECodexis to Report First Quarter 2024 Financial Results on..
11/4/202413:05GLOBECodexis Appoints Carole Cobb, MBA, to Strategic Advisory..
06/3/202422:02EDGAR2Form 8-K - Current report
28/2/202422:05GLOBECodexis Reports Fourth Quarter and Fiscal Year 2023..
27/2/202418:15APSBiotech Rallied Strongly On Exclusive Licensing Agreement
26/2/202422:05GLOBECodexis Enters Exclusive Licensing Agreement for Newly..
26/2/202414:05GLOBECodexis to Participate in TD Cowen 44th Annual Health Care..
20/2/202414:05GLOBECodexis Announces Appointment of Masad Damha, PhD, and Jim..
16/2/202422:01EDGAR2Form 8-K - Current report
14/2/202422:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:05GLOBECodexis to Report Fourth Quarter and Fiscal Year 2023..
13/2/202422:19EDGAR2Form 8-K - Current report
13/2/202422:05GLOBECodexis Secures $40 Million in Strategic Financing Deal with..
09/2/202422:06EDGAR2Form 8-K - Current report
01/2/202422:05GLOBEseqWell and Codexis to Unveil Engineered Transposase Enzyme..
24/1/202420:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/1/202414:30EDGAR2Form 8-K - Current report
03/1/202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202403:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202403:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202314:30GLOBECodexis Announces Purchase Agreement with Nestlé Health..
27/12/202314:30EDGAR2Form 8-K - Current report
13/12/202322:06GLOBECodexis and Aldevron Enter Exclusive Licensing Agreement for..
13/12/202322:05GLOBECodexis Announces Achievement of Gram-scale Synthesis with..
11/12/202313:05GLOBECodexis KOL Event Highlights Significant Need for an..
28/11/202322:05GLOBECodexis to Host Virtual KOL Event on its ECO Synthesis™..
17/11/202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202323:31EDGAR2Form 144 - Report of proposed sale of securities
14/11/202322:05GLOBECodexis to Participate in 35th Annual Piper Sandler..
03/11/202321:26EDGAR2Form 8-K/A - Current report: [Amend]
03/11/202321:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:16EDGAR2Form 8-K - Current report
02/11/202321:05GLOBECodexis Reports Third Quarter 2023 Financial Results
31/10/202321:05GLOBECodexis to Participate in Upcoming Healthcare Conferences
27/10/202321:35GLOBECodexis to Present Update on ECO Synthesis™ Platform at..
26/10/202322:05GLOBECodexis to Present Update on ECO Synthesis™ Platform at..
19/10/202322:05GLOBECodexis to Report Third Quarter 2023 Financial Results on..
29/9/202313:05GLOBECodexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton..
22/9/202322:32EDGAR2Form 8-K - Current report
18/9/202322:05GLOBECodexis CEO Stephen Dilly Named as Finalist of 2023 Bloom..
12/9/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202322:05GLOBECodexis to Participate in Cantor Global Healthcare..
07/9/202322:05EDGAR2Form 8-K - Current report
07/9/202322:05GLOBECodexis Announces Agreement for Assignment and Assumption of..
03/8/202322:54EDGAR2Form S-8 - Securities to be offered to employees in employee..

Dernières Valeurs Consultées

NASDAQ
CDXS
Codexis
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés